Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

357 results about "Atrophic gastritis" patented technology

Atrophic gastritis is a process of chronic inflammation of the gastric mucosa of the stomach, leading to a loss of gastric glandular cells and their eventual replacement by intestinal and fibrous tissues. As a result, the stomach's secretion of essential substances such as hydrochloric acid, pepsin, and intrinsic factor is impaired, leading to digestive problems. The most common are vitamin B₁₂ deficiency which results in a megaloblastic anemia and malabsorption of iron, leading to iron deficiency anaemia. It can be caused by persistent infection with Helicobacter pylori, or can be autoimmune in origin. Those with the autoimmune version of atrophic gastritis are statistically more likely to develop gastric carcinoma, Hashimoto's thyroiditis, and achlorhydria.

Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof

The invention discloses a Chinese medicine composite for treating chronic atrophic gastritis and a preparation method thereof. The Chinese medicine composite mainly comprises the following active pharmaceutical ingredients: jobstears seed, rhizoma dioscoreae, pericarpium citri reticulatae, fructus aurantii immaturus, radix aristolochiae, ligusticum chuanxiong, Lignum aquilariae resinatum, rhizoma corydalis, stir-fried frankincense, stir-fried myrrh, pericarpium citri reticulatae viride, radix scrophulariae, rhizoma cyperi, styrax, radix trichosanthis, radix rehmanniae preparata, peach seed, safflower, medicated leaven, fructus setariae germinatus, dandelion, honeysuckle flower, rhizoma coptidis, radix et rhizoma rhei, radish seed, rhizoma curcumae longae, grassleaf sweetflag rhizome, cortex magnoliae officinalis and tuckahoe, and the like. The Chinese medicine composite can be prepared to be any common oral preparation according to the conventional Chinese medicine preparation method. The Chinese medicine composite can obviously improve abdominal distention that is manifest due to more food intake, tastelessness and insipidity, vague pain and complaint in the gastric cavity, lassitude, athrepsy, anorexia, anaemia and the like and the complications including gastric bleeding, gastrelcosis, anaemia and gastric cancer, and the like, which has definite clinical effect, obvious curative effect and fast desired effect.
Owner:TAIYI HEPU BEIJING RES INST OF TCM

Vascular four-dimensional reconstruction method in NOT gate-controlled ICUS (intravascular ultrasound) image sequence

The invention discloses a vascular four-dimensional reconstruction method in a NOT gate-controlled ICUS (intravascular ultrasound) image sequence. The method comprises the following steps: accurately positioning an ultrasonic catheter retracement path by utilizing a pair of approximate orthorhombic CAG (chronic atrophic gastritis) image sequences collected with an ICUS image synchronously; carrying out four-dimensional reconstruction on a morphological structure of a target vessel section containing possibly existing plaques through combining the cross section information of a vessel lomen extracted from the ICUS image; and reproducing true forms of coronary vessels at each time phase in a cardiac cycle. With the adoption of the vascular four-dimensional reconstruction method in the NOT gate-controlled ICUS image sequence, the four-dimensional reconstruction of the morphological structure of a coronary artery target vessel section containing the possibly existing plaques is realized, the true forms of the target vessel section at different time phases in the cardiac cycle can be comprehensively and truly reflected; and more reliable accordance can be provided for clinical diagnosis and treatment of coronary arteriesarteriosclerosis osteolytic lesions and research of biomechanical characteristics of coronary artery vascular tissues and the like. The method does not need an ECG-gating acquisition device, and also does not need ECG signals, so that the interventional examination time is greatly shortened, and the requirements on the original image data are reduced.
Owner:NORTH CHINA ELECTRIC POWER UNIV (BAODING)

Medicine for treating reflux esophagitis and preparation method thereof

The invention belongs to the technical field of proprietary Chinese medicines, and particularly relates to a medicine for treating reflux esophagitis and a preparation method thereof. The invention mainly aims at solving the problems of the existing medicine for treating reflux esophagitis that long-term use of the medicine is easy to incur atrophic gastritis, symptoms and diseases are easy to relapse after medicine withdrawal, curative effect is poor, and the like. In the invention, radix bupleuri, radix paeoniae alba, fructus aurantii immaturus, tangerine peel, ligusticum chuanxiong hort, gardenia jasminoides ellis, rhizoma coptidis, pinellia ternate, evodia rutaecarpa, semen raphani, nacre and glycyrrhiza uralensis are mainly taken as active pharmaceutical ingredients of the medicine, and the specific preparation method comprises the following steps: firstly heating the fructus aurantii immaturus with bran, processing the pinellia ternate with ginger, dry-frying the semen raphani, processing the glycyrrhiza uralensis with honey, then putting the medicines together with the remaining other medicines in a container, adding a certain amount of water for decoction, concentrating decoction to clear cream, drying, preparing fine powder, adding lactose and aspartame in the fine powder, evenly mixing to prepare granules, and packaging after sterilization, so as to obtain the medicine. The medicine has the advantages of stable curative effect, lower recurrence rate after medicine withdrawal and the like.
Owner:SHANXI YELLOW RIVER TRADITIONAL CHINESE MEDICINE

Stomach medicine

The invention relates to stomach medicine and belongs to a pure Chinese herbal medicine preparation. The stomach medicine comprises the following ingredients according to the weight ratio: 250g of paenoiae alba, 120g of citron, 100g of szechwan chinaberry fruit, 80g of rhizoma corydalis, 120g of combined spicebush root, 80g of pseudo-ginseng, 120g of fructus amomi, 70g of elecampane, 120g of radix curcumae, 150g of white atractylodes rhizome, 120g of rhizoma cyperi, 80g of liquorice, 250g of lily, 80g of angelica sinensis, 110g of endothelium corneum gigeriae galli, 80g of galangal, 250g of dandelion and 250g of sculellaria barbata. All recipes are matched, and the effects of nourishing the liver to soften the liver, dredging the hysteresis to harmonize the stomach, invigorating the spleen to supplement qi, and promoting blood circulation to remove blood stasis and relive pain are reached. The whole recipe is mild but not dry and is supplementary and but not sluggish, in addition, the medicine property is gentle, and the stomach medicine can be taken for a long time and approaches to the modern dietary therapy. For peptic ulcer, the six-week ulcer healing rate is 92 percent, the chronic gastritis elimination rate is 93 percent, the stomach medicine has an obvious therapeutic effect on the chronic atrophic gastritis without the therapeutic effect in the prior art and has better therapeutic effects on difficult-to-treat stomach illnesses on which the therapeutic effect of other medicine is poor, and long-term clinical practices show that the stomach medicine does not have any toxic or side effect.
Owner:康厚彬

Method for building spleen-deficiency chronic atrophic gastritis gastric precancerous lesions animal model

InactiveCN102648701ASyndrome of spleen deficiencyHave body temperatureIn-vivo testing preparationsAnimal husbandryNitrosoRat model
The invention relates to a method for building a spleen-deficiency chronic atrophic gastritis gastric precancerous lesions animal model. The method is based on the existing spleen-deficiency rat model and the existing chronic atrophic gastritis rat model and is used for building the animal model through united copy of free drinking of N-methyl-N '-nitro-N -nitrosoguanidine (MNNG) solution, irregular eating and purgation. The method comprises the following specific steps of: preparing 10mg / L MNNG storage solution by utilizing sterilized tap water, preparing 80 to 200 mug / mL MNNG solution in temporary use to substitute the drinking water to be drunk freely by the rats, and adopting the free drinking of MNNG as the beginning of the modeling; copying a spleen-deficiency syndrome through irregular eating and improved purgation way, feeding the rats on alternate days since the fifth week after the modeling, and utilizing qi-activating decoction for gavage in a dose of 1 to 3ml per rat every day in the seventh weak; and continuing the modeling for 12 weeks. The animal model built through the method is identical to or similar with the clinical syndrome and physical signs of middle-late lesions in chronic atrophic gastritis. After being verified in repeatedly modeling, the method has good repeatability and good stability. The built model is suitable for selecting traditional Chinese medicine for treating the chronic atrophic gastritis through a traditional Chinese medicine spleen treatment method.
Owner:潘华峰

Traditional Chinese medicinal composition for treating chronic atrophic gastritis and preparation method of traditional Chinese medicinal composition

The invention discloses a traditional Chinese medicinal composition for treating chronic atrophic gastritis. The traditional Chinese medicinal composition is prepared from the following crude medicines in parts by weight: 40 parts of radix pseudostellariae, 50 parts of dendrobe, 5 parts of pseudo-ginseng, 40 parts of curcuma zedoary, 40 parts of radix curcumae, 20 parts of radix paeoniae alba, 40 parts of oldenlandia diffusa, 45 parts of dandelion, 45 parts of sculellaria barbata, 10 parts of mangnolia officinalis, 7 parts of agastache rugosus, 7 parts of eupatorium, 7 parts of pericarpium citri reticulatae, 8 parts of pinellia ternata, 8 parts of costus root, 8 parts of fructus amomi, 8 parts of cattail pollen, 8 parts of trogopterus dung, 4 parts of liquorice, 10 parts of cassia twig, 10 parts of caulis bambusae in taeniam, 30 parts of reed rhizome, 10 parts of bitter orange, 10 parts of radix ophiopogonis and 20 parts of honeysuckle. The traditional Chinese medicinal composition is rational in formula, and various traditional Chinese medicines take a synergistic action to enhance therapeutic effect which, in comparison with Western medicine, is more excellent; the traditional Chinese medicinal composition treats both symptoms and root causes, and is high in cure rate, low in recurrence rate, light in irritation to stomach; the composition relieves body burden.
Owner:刘金军

Oral liquid for treating chronic atrophic gastritis

The invention belongs to the technical field of traditional Chinese medicines and relates to oral liquid for treating chronic atrophic gastritis. The oral liquid is prepared by the following components in parts by weight: 10 parts of Zhejiang white atractylodes rhizome, 15 parts of poria cocos, 10 parts of orange peel, 10 parts of pinellia tenata breit, 10 parts of vinegar rhizoma cyperi, 10 parts of fructus amomi, 10 parts of mangnolia officinalis, 10 parts of vinegar curcuma aromatic, 15 parts of artemisia anomala, 6 parts of cassia twig, 10 parts of rhizoma corydalis, 10 parts of hawthorn, 10 parts of roasted malt, 10 parts of roasted medicated leaven, 10 parts of lindera aggregate, 15 parts of radix paeoniae alba, 12 parts of radix pseudostellariae and 3 parts of liquorice. The oral liquid provided by the invention has the effects of relieving inflammatory cell infiltration, regulating cellular immunity and humoral immunity function, restraining the activity of pepsinogen to promote proliferation and recovery thereof, strengthening barrier protection function of the mucosa, regulating gastrointestinal motility, increasing permeability of gastric mucosa, improving blood circulation of the mucosa, promoting atrophic glands to recover, and delaying or reversing progression of diseases.
Owner:李郑生
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products